SPINRAZA, created in 2014 (United States), from
61 sister brands
and 17479 competing brands.
The SPINRAZA brand is owned by Biogen Idec, a company listed in New York.
The sector of SPINRAZA is Drug Manufacturers.
Only companies with a strong brand or unique know-how benefit from this ability to set their prices without impacting demand and thus preserve their margins.